Division of Translational Cancer Research
201 – 210 of 695
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
- Contribution to journal › Article
-
Mark
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer : Results from the Prospective, International, Observational Prostate Cancer Registry
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
- Contribution to journal › Article
-
Mark
Rapid marine oxygen variability : Driver of the Late Ordovician mass extinction
- Contribution to journal › Article
-
Mark
Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics : Involvement of RIP1 and cFLIP
- Contribution to journal › Article
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
- Contribution to journal › Scientific review
-
Mark
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
- Contribution to journal › Article
-
Mark
Regulatory networks and 5' partner usage of miRNA host gene fusions in breast cancer
- Contribution to journal › Article
-
Mark
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
- Contribution to journal › Article
